Onderneming Lexaria Corp Other OTC
Aandelen
US52886N2080
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Intellectual Property Licensing
64,9
%
| 0 | 21,4 % | 0 | 64,9 % | +169,06% |
Business-to-business Product
19,5
%
| 0 | 44,4 % | 0 | 19,5 % | -61,07% |
Research & Development
15,6
%
| 0 | 21,5 % | 0 | 15,6 % | -35,69% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -11,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 26-10-06 | |
John Docherty
PSD | President | 53 | 15-04-15 |
George Jurcic
IRC | Investor Relations Contact | - | 01-05-21 |
Vanessa Carle
LAW | General Counsel | - | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 26-10-06 | |
Nicholas Baxter
BRD | Director/Board Member | 70 | 08-07-11 |
Albert Reese
BRD | Director/Board Member | 74 | 14-01-21 |
John Docherty
PSD | President | 53 | 15-04-15 |
Director/Board Member | 76 | 16-09-15 | |
Catherine Turkel
BRD | Director/Board Member | 63 | 02-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 885 673 | 11 240 368 ( 87,23 %) | 0 | 87,23 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 705 mld. | |
+32,82% | 583 mld. | |
-3,51% | 364 mld. | |
+19,94% | 332 mld. | |
+5,14% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+9,32% | 169 mld. |
- Beurs
- Aandelen
- Koers LEXX
- Koers
- Onderneming Lexaria Corp